Table III.
Postbronchodilator FEV1 (% predicted), asthmatic patients | Postbronchodilator FEV1 (% predicted), patients with COPD | Postbronchodilator FEV1/FVC (%), asthmatic patients | Postbronchodilator FEV1/FVC (%), patients with COPD | |
---|---|---|---|---|
Mean LA/BSA (mm2/m2) | 0.324† | 0.241* | 0.218† | 0.082 |
Mean TA/BSA (mm2/m2) | 0.287† | 0.238* | 0.171* | 0.084 |
Mean WA/BSA (mm2/m2) | 0.247† | 0.226* | 0.126 | 0.083 |
Mean %WA | −0.417† | −0.248* | −0.343† | −0.121 |
MLDE/I | −0.303† | −0.697† | −0.402† | −0.729† |
Perc15 (HU) | 0.178* | 0.434† | 0.408† | 0.554† |
LAC-D−950 | 0.190* | 0.180 | 0.234† | 0.245* |
FVC, Forced vital capacity.
Pearson correlation coefficient: *P < 0.05 and †P < .005.